TRACE BIOSCIENCES INC
Portland, OR · Medtech · Private
Near-infrared fluorescent imaging probes for intraoperative visualization of cancer margins and nerve tissue during head and neck surgery
trace-bio.com →- Grants
- $2.1M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $4.2M
- 1 award · Health and Human S
- #135 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Two-Color Near-Infrared Fluorescence Guided Surgery Tools Enabling Simultaneous Cancer Margin and Nerve Visualization during Head and Neck Squamous Cell Carcinoma Resection | $386,211 | |
| Federal grant | Department of Health and Human Services · Phase II · Clinical Translation of Near Infrared Nerve-Specific Fluorophores for Nerve-sparing Prostatectomy | $937,594 | |
| Federal contract | Department of Health and Human Services · Arpa-h SBIR Phase II Topic Arpa-h 04 Intra-operative Contrast Agents | $4,218,974 | |
| Federal grant | Department of Health and Human Services · Phase II · Clinical Translation of Near Infrared Nerve-Specific Fluorophores for Nerve-sparing Prostatectomy | $810,809 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 132 | ADAPTIVE BIOTECHNOLOGIES CORPORATION | $4.4M | $507M |
| 133 | L2 DIAGNOSTICS LLC | $4.4M | — |
| 134 | NUSHORES BIOSCIENCES LLC | $4.3M | $350K |
| 135 | TRACE BIOSCIENCES INC | $4.2M | — |
| 136 | ShockWave Medical, Inc. | $4.2M | $110M |
| 137 | NOWDiagnostics, Inc. | $4.1M | $43M |
| 138 | SILK TECHNOLOGIES, LTD. | $4.1M | $5.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.